Concepedia

Jamunarani Veeraraghavan

JV

29

Publications

1.6K

Citations

20

H-Index

2009

Active since

Affiliations

Baylor College of Medicine(Current)

University of Oklahoma Health Sciences Center

The University of Texas Health Science Center at San Antonio

Dana-Farber Cancer Institute

University of Oklahoma

Jamunarani Veeraraghavan is an author at Baylor College of Medicine specializing in medicine, radiation oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2009–2023

29

Publications

29

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Xiaoyong Fu, Resel Pereira, Carmine De Angelis et al. · Proceedings of the National Academy of Sciences · 2019 · 164 citations · Full text

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Aleix Prat, Tomás Pascual, Carmine De Angelis et al. · JNCI Journal of the National Cancer Institute · 2019 · 163 citations · Full text

Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers

Jamunarani Veeraraghavan, Ying Tan, Xi-Xi Cao et al. · Nature Communications · 2014 · 147 citations · Full text

, , +12

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

Xiaowei Xu, Carmine De Angelis, Kathleen A. Burke et al. · Clinical Cancer Research · 2017 · 122 citations · Full text

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo et al. · Clinical Cancer Research · 2021 · 91 citations · Full text

Rows per page

1–5 of 29